BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38275116)

  • 1. Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial.
    Sajobi TT; Arimoro OI; Ademola A; Singh N; Bala F; Almekhlafi MA; Deschaintre Y; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz GJ; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JS; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra SM; Gioia LC; Jalini S; Cayer C; Phillips SJ; Elamin E; Shoamanesh A; Subramaniam S; Kate MP; Jacquin G; Camden MC; Benali F; Alhabli I; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe AY; Sehgal A; Zhang Q; Lethebe B; Doram C; Shamy M; Kenney C; Buck BH; Swartz RH; Menon BK
    Stroke; 2024 Mar; 55(3):524-531. PubMed ID: 38275116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
    Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
    Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
    Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase.
    Kim DJ; Singh N; Catanese L; Yu AYX; Demchuk AM; Lloret-Villas MI; Deschaintre Y; Coutts SB; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Manosalva H; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Phillips S; Hill MD; Poppe AY; Ademola A; Shamy M; Bala F; Sajobi TT; Swartz RH; Almekhlafi MA; Menon BK; Field TS
    Stroke; 2024 Feb; 55(2):288-295. PubMed ID: 38174568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenecteplase, 0.4 mg/kg, in Moderate and Severe Acute Ischemic Stroke: A Pooled Analysis of NOR-TEST and NOR-TEST 2A.
    Novotny V; Kvistad CE; Naess H; Logallo N; Fromm A; Khanevski AN; Thomassen L
    J Am Heart Assoc; 2023 Oct; 12(20):e030320. PubMed ID: 37830342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
    Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke: A Prespecified Secondary Analysis of the ACT Randomized Clinical Trial.
    Bala F; Singh N; Buck B; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Appireddy R; Moreau F; Phillips S; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Williams H; Field TS; Manosalva Alzate A; Siddiqui M; Zafar A; Imoukhoude O; Hunter G; Alhabli I; Benali F; Horn M; Hill MD; Shamy M; Sajobi TT; Swartz RH; Menon BK; Almekhlafi M
    JAMA Neurol; 2023 Aug; 80(8):824-832. PubMed ID: 37428494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
    Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
    Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke: The Comparative Effectiveness of Routine Tenecteplase vs Alteplase in Acute Ischemic Stroke (CERTAIN) Collaboration.
    Warach SJ; Ranta A; Kim J; Song SS; Wallace A; Beharry J; Gibson D; Cadilhac DA; Bladin CF; Kleinig TJ; Harvey J; Palanikumar L; Doss VT; Marescalco R; Fink JN; Tyson A; Schlick KH; Noh L; Wilson D; Figueroa S; Pech MA; Paletz LB; Lewis MK; Castro M; Sahlein DH; Lafranchise EF; Sandall J; Asif KS; Geraghty SR; Cullis PA; Malisch T; Neill TA; LaMonte MP; Campbell BCV; Wu TY
    JAMA Neurol; 2023 Jul; 80(7):732-738. PubMed ID: 37252708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
    Rønning OM; Logallo N; Thommessen B; Tobro H; Novotny V; Kvistad CE; Aamodt AH; Næss H; Waje-Andreassen U; Thomassen L
    Stroke; 2019 Feb; 50(2):498-500. PubMed ID: 30602354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
    Wang Y; Li S; Pan Y; Li H; Parsons MW; Campbell BCV; Schwamm LH; Fisher M; Che F; Dai H; Li D; Li R; Wang J; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X;
    Lancet; 2023 Feb; 401(10377):645-654. PubMed ID: 36774935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
    Roaldsen MB; Eltoft A; Wilsgaard T; Christensen H; Engelter ST; Indredavik B; Jatužis D; Karelis G; Kõrv J; Lundström E; Petersson J; Putaala J; Søyland MH; Tveiten A; Bivard A; Johnsen SH; Mazya MV; Werring DJ; Wu TY; De Marchis GM; Robinson TG; Mathiesen EB;
    Lancet Neurol; 2023 Feb; 22(2):117-126. PubMed ID: 36549308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Quality of Life After Intravenous Alteplase for Stroke in the WAKE-UP Trial.
    Jensen M; Sehner S; Cheng B; Schlemm E; Quandt F; Barow E; Wegscheider K; Boutitie F; Ebinger M; Endres M; Fiebach JB; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Thomalla G; Gerloff C
    Neurology; 2023 Jan; 100(2):e154-e162. PubMed ID: 36302662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenecteplase versus alteplase after acute ischemic stroke at high age.
    Thommessen B; Næss H; Logallo N; Kvistad CE; Waje-Andreassen U; Ihle-Hansen H; Ihle-Hansen H; Thomassen L; Morten Rønning O
    Int J Stroke; 2021 Apr; 16(3):295-299. PubMed ID: 32631157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials.
    Bivard A; Huang X; McElduff P; Levi CR; Campbell BC; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
    Circulation; 2017 Jan; 135(5):440-448. PubMed ID: 27965285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke.
    Tsivgoulis G; Katsanos AH; Christogiannis C; Faouzi B; Mavridis D; Dixit AK; Palaiodimou L; Khurana D; Petruzzellis M; Psychogios K; Macleod MJ; Ahmed N
    Ann Neurol; 2022 Sep; 92(3):349-357. PubMed ID: 35713213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.